Greg Wiederrecht
Vice President & Head, External Scientific Affairs Worldwide Licensing & External Research Merck & Co., Inc.

Dr. Greg Wiederrecht is the Vice President and Head of External Scientific Affairs (ESA) in the Merck Research Laboratories division of Merck & Co., Inc. where he has been employed for the past 20 years. ESA is responsible for the scientific assessment of all licensing, partnering, and acquisition opportunities for Merck. Dr. Wiederrecht’s responsibilities include the management of a group of 80 scientists and administrators, distributed worldwide and divided by various therapeutic and platform areas, who identify and assess opportunities outside of Merck’s walls.

Dr. Wiederrecht holds a B.S. degree from the University of California, Irvine and a PhD in biochemistry from M.I.T. Before joining Merck in 1989, he was a Helen Hay Whitney Post-Doctoral Fellow and an American Cancer Society Senior Post-Doctoral Fellow at Caltech. Dr. Wiederrecht has published 48 peer reviewed manuscripts and book chapters and has been an invited speaker at more than 45 conferences.